Challenges of Treatment Adherence in Older Patients with Parkinson's Disease

ISSN： 1170-229X

Source： Drugs & Aging, Vol.26, Iss.2, 2009-01, pp. : 145-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Parkinson's Disease: A Survey of Patients and Neurologists

By Fargel Matthias

Clinical Drug Investigation, Vol. 27, Iss. 3, 2007-01 ,pp. : 207-218

Adis International

Access to resources Recommend Favorite

The Role of Dopamine Agonists in the Treatment of Depression in Patients with Parkinson's Disease: A Systematic Review

By Leentjens Albert F.G.

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 273-286

Adis International

Access to resources Recommend Favorite

Depression in Patients with Parkinson's Disease: Epidemiology, Pathophysiology and Treatment Options

By Zesiewicz T.A.

CNS Drugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 253-264

Adis International

Access to resources Recommend Favorite

Safinamide in the treatment of Parkinson's disease

By Schapira Anthony HV

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2261-2268

Informa Healthcare

Access to resources Recommend Favorite

Istradefylline for the treatment of Parkinson's disease

By Park Ariane Stacy Mark

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. : 111-114

Informa Healthcare

Access to resources Recommend Favorite